Literature DB >> 1447474

Basis for body weight exponent (0.75) as a scaling factor in energy metabolism and risk assessment.

K S Sidhu1.   

Abstract

The basis that led to the adoption of the exponent (0.75) as a scaling factor for the relationship between body weight and energy metabolism is presented. In the risk assessment formulation, it may be appropriate to use the 0.75 power of body weight as a scaling factor for carcinogenicity data obtained from animal studies.

Mesh:

Year:  1992        PMID: 1447474     DOI: 10.1002/jat.2550120503

Source DB:  PubMed          Journal:  J Appl Toxicol        ISSN: 0260-437X            Impact factor:   3.446


  4 in total

1.  Overexpression of corticotropin-releasing factor in the nucleus accumbens enhances the reinforcing effects of nicotine in intact female versus male and ovariectomized female rats.

Authors:  Kevin P Uribe; Victor L Correa; Briana E Pinales; Rodolfo J Flores; Bryan Cruz; Zhiying Shan; Adriaan W Bruijnzeel; Arshad M Khan; Laura E O'Dell
Journal:  Neuropsychopharmacology       Date:  2019-10-15       Impact factor: 7.853

2.  Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats.

Authors:  Thomas N Greenwell; Cindy K Funk; Pietro Cottone; Heather N Richardson; Scott A Chen; Kenner C Rice; Eric P Zorrilla; George F Koob
Journal:  Addict Biol       Date:  2009-04       Impact factor: 4.280

3.  The alpha1 adrenergic receptor antagonist prazosin reduces heroin self-administration in rats with extended access to heroin administration.

Authors:  Thomas N Greenwell; Brendan M Walker; Pietro Cottone; Eric P Zorrilla; George F Koob
Journal:  Pharmacol Biochem Behav       Date:  2008-07-23       Impact factor: 3.533

Review 4.  Scaling basic toxicokinetic parameters from rat to man.

Authors:  K Bachmann; D Pardoe; D White
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.